| Study of the Glutaminase Inhibitor CB-839 in Solid Tumors (NCT02071862) | Calithera Biosciences, Inc | 2014-02-01 |
| Rapid Autopsy and Procurement of Cancer Tissue (NCT01851395) | National Cancer Institute (NCI) | 2013-12-30 |
| Integrated Cancer Repository for Cancer Research (NCT02012699) | University of Nebraska | 2013-11-01 |
| Nintedanib (BIBF 1120) in Mesothelioma (NCT01907100) | Boehringer Ingelheim | 2013-09-19 |
| Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma (NCT01950572) | National Cancer Institute (NCI) | 2013-09-09 |
| Thromboelastography During Surgery for Malignant Pleural Mesothelioma (NCT01912547) | Brigham and Women's Hospital | 2013-09-01 |
| Feasibility of an Early Palliative Care Intervention for Metastatic Cancer Patients. A Phase 2 Study. (NCT02078700) | Azienda USL Reggio Emilia - IRCCS | 2013-07-01 |
| A Phase II Trial to Assess TroVax® Plus Chemotherapy in Patients With Malignant Pleural Mesothelioma (NCT01569919) | Wales Cancer Trials Unit | 2012-12-01 |
| Early Detection of Lung Cancer and Mesothelioma in Workers Exposed to Asbestos (NCT01719068) | British Columbia Cancer Agency | 2012-10-01 |
| Mithramycin for Lung, Esophagus, and Other Chest Cancers (NCT01624090) | National Cancer Institute (NCI) | 2012-09-06 |
| CAR T Cell Receptor Immunotherapy Targeting Mesothelin for Patients With Metastatic Cancer (NCT01583686) | National Cancer Institute (NCI) | 2012-05-04 |
| The ISET (Isolation by Size of Epithelial Tumor Cells) and the CellSearch Methods in Malignant Pleural Mesothelioma (NCT01776385) | Centre Hospitalier Universitaire de Nice | 2012-02-01 |
| A Single-Dose Pilot Study of Radiolabeled Amatuximab (MORAb-009) in Mesothelin Over Expressing Cancers (NCT01521325) | Morphotek | 2011-09-01 |
| Molecular Analysis of Thoracic Malignancies (NCT01385722) | Stanford University | 2011-08-01 |
| Amatuximab for High Mesothelin Cancers (NCT01413451) | National Cancer Institute (NCI) | 2011-07-12 |
| Chest Wall Motion Analysis in Disease (NCT02958683) | Heart of England NHS Trust | 2011-07-01 |
| SS1P and Pentostatin Plus Cyclophosphamide for Mesothelioma (NCT01362790) | National Cancer Institute (NCI) | 2011-05-11 |
| Early Palliative Care in Advanced Lung and Gastrointestinal Malignancies (NCT01401907) | Massachusetts General Hospital | 2011-05-01 |
| Psychosocial Needs and Exploration of Online Support for Patients With Mesothelioma (NCT01356251) | Memorial Sloan Kettering Cancer Center | 2011-05-01 |
| Pulmonary Interstitial Lymphography in Early Stage Lung Cancer (NCT01188486) | Stanford University | 2010-08-01 |
| Radical Pleurectomy/Decortication (PD) and Intensity Modulated Radiotherapy (IMRT) (NCT01134146) | M.D. Anderson Cancer Center | 2010-05-27 |
| Combination Gene Transfer and Chemotherapy (NCT01119664) | Abramson Cancer Center at Penn Medicine | 2010-04-27 |
| Isolated Thoracic Perfusion (ITP-F) for MPM (NCT02467426) | Medias Klinikum for Surgical Oncology | 2009-09-01 |
| Peritoneal Surface Malignancies - Characterization, Models and Treatment Strategies (NCT02073500) | Oslo University Hospital | 2009-09-01 |
| Velcade and Eloxatin for Patients With Malignant Pleural or Peritoneal Mesothelioma (NCT00996385) | Columbia University | 2009-09-01 |
| Pilot Study of Bisphosphonate Therapy (Zoledronic Acid) in Patients With Malignant Mesothelioma (UAB 0901) (NCT01204203) | University of Alabama at Birmingham | 2009-06-01 |
| CryoSpray Ablation(tm)Thoracic Patient Registry (NCT00785239) | CSA Medical, Inc. | 2009-04-01 |
| Pemetrexed (ALIMTA) Plus Cisplatin Followed by Surgery and Radiation Therapy for Mesothelioma (NCT00895648) | University Health Network, Toronto | 2009-01-01 |
| B-Receptor Signaling in Cardiomyopathy (NCT01135849) | Daniel Bernstein | 2008-11-01 |
| Sorafenib in Previously Treated Malignant Mesothelioma (NCT00794859) | King's College London | 2008-10-01 |
| CryoSpray Ablation(tm)in Malignant Airway Disease to Determine Safety, and Tissue Effect in the Lung (ICE the MAD) (NCT00748085) | CSA Medical, Inc. | 2008-10-01 |
| Cisplatin With Alimta or Gemcitabine in Long Infusion for Mesothelioma (NCT01281800) | Institute of Oncology Ljubljana | 2008-08-01 |
| Sorafenib, Pemetrexed, and Cisplatin in Treating Patients With Advanced Solid Tumors (NCT00703638) | Masonic Cancer Center, University of Minnesota | 2008-05-01 |
| A Study of VEGF-Antisense Oligonucleotide in Combination With Pemetrexed and Cisplatin for the Treatment of Advanced Malignant Mesothelioma (NCT00668499) | University of Southern California | 2008-04-01 |
| N-AcetylCysteine vs. Placebo to Prevent Neurotoxicity Induced by Platinum Containing Chemotherapy (NCT00637624) | Rijnstate Hospital | 2008-03-01 |
| Mesothelioma Avastin Plus Pemetrexed-cisplatin Study (NCT00651456) | Intergroupe Francophone de Cancerologie Thoracique | 2008-02-01 |
| A Phase II Study of the Association of Glivec® Plus Gemzar® in Patients With Unresectable, Refractory, Malignant Mesothelioma (NCT00551252) | Gruppo Italiano MEsotelioma | 2008-01-01 |
| An Efficacy and Safety Study With Vandetanib to Treat Inoperable or Relapsed Malignant Mesothelioma (NCT00597116) | Genzyme, a Sanofi Company | 2007-12-01 |
| SS1(dsFV)PE38 Plus Pemetrexed and Cisplatin to Treat Malignant Pleural Mesothelioma (NCT01445392) | National Cancer Institute (NCI) | 2007-11-14 |
| Carboplatin, Bevacizumab and Pemetrexed in the First-Line Treatment of Patients With Malignant Pleural Mesothelioma (MPM) (NCT00604461) | H. Lee Moffitt Cancer Center and Research Institute | 2007-10-01 |
| Phase II Study of Bevacizumab, Pemetrexed and Carboplatin as First-Line Therapy in Malignant Pleural Mesothelioma (NCT00407459) | Armando Santoro, MD | 2007-09-01 |
| Surgery Plus Intraoperative Peritoneal Hyperthermic Chemotherapy (IPHC) to Treat Peritoneal Carcinomatosis (NCT00454519) | Wuhan University | 2007-03-01 |
| Study of Pemetrexed in Mesothelioma and Lung Cancer Patients With Fluid Around the Lungs or Abdomen (NCT00316225) | Eli Lilly and Company | 2006-12-01 |
| Tomotherapy Treatment for Mesothelioma (NCT00469196) | AHS Cancer Control Alberta | 2006-10-01 |
| Cisplatin, Pemetrexed, and Imatinib Mesylate in Malignant Mesothelioma (NCT00402766) | M.D. Anderson Cancer Center | 2006-08-01 |
| A Study of MORAb-009 in Subjects With Pancreatic Cancer, Mesothelioma, or Certain Types of Ovarian or Lung Cancer (NCT00325494) | Morphotek | 2006-05-01 |
| Pemetrexed Plus Gemcitabine or Carboplatin for Patients With Advanced Malignant Pleural Mesothelioma (NCT00101283) | Eastern Cooperative Oncology Group | 2006-02-23 |
| Cisplatin, Pemetrexed and Bevacizumab for Untreated Malignant Mesothelioma (NCT00295503) | University of Texas Southwestern Medical Center | 2006-02-01 |
| Suberoylanilide Hydroxamic Acid (Vorinostat, MK-0683) Versus Placebo in Advanced Malignant Pleural Mesothelioma (MK-0683-014) (NCT00128102) | Merck Sharp & Dohme LLC | 2005-06-30 |
| Early Diagnosis of Lung Cancer and Mesothelioma in Prior Asbestos Workers (NCT00188890) | University Health Network, Toronto | 2005-03-01 |
| Depsipeptide/Flavopiridol Infusion for Cancers of the Lungs, Esophagus, Pleura, Thymus or Mediastinum (NCT00094978) | National Cancer Institute (NCI) | 2004-10-25 |
| Eloxatin® Plus Gemcitabine Chemotherapy for Mesothelioma (NCT00859469) | Columbia University | 2004-04-01 |
| Bevacizumab (Avastin) and Erlotinib (Tarceva) in Previously Treated Mesothelioma (NCT00137826) | Dana-Farber Cancer Institute | 2004-02-01 |
| Serum Biomarkers in Diagnosis of Mesothelioma (NCT02029105) | Eskisehir Osmangazi University | 2004-01-01 |
| An Open-label, Phase II Trial of ZD1839 (IRESSA) in Patients With Malignant Mesothelioma (NCT00787410) | AstraZeneca | 2003-09-01 |
| Pemetrexed Plus Gemcitabine as Front-Line Chemotherapy for Patients With Malignant Pleural or Peritoneal Mesothelioma (NCT00061477) | Eli Lilly and Company | 2002-12-01 |
| A Study Comparing Pemetrexed Plus Best Supportive Care Versus Best Supportive Care Alone in the Treatment of Mesothelioma (NCT00190762) | Eli Lilly and Company | 2001-10-01 |
| Treatment of Peritoneal Cancer With Surgery, Perfused Heated Cisplatin and Chemotherapy (NCT00004547) | National Cancer Institute (NCI) | 2000-01-01 |
| ALIMTA (Pemetrexed) Alone or in Combination With Cisplatin for Patients With Malignant Mesothelioma. (NCT00040625) | Eli Lilly and Company | |